244 related articles for article (PubMed ID: 6807534)
1. Drug activity and therapeutic synergism in cancer treatment.
Carter WH; Wampler GL; Stablein DM; Campbell ED
Cancer Res; 1982 Aug; 42(8):2963-71. PubMed ID: 6807534
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia.
Wampler GL; Carter WH; Campbell ED; Goldman ID
Cancer Treat Rep; 1987 Jun; 71(6):581-91. PubMed ID: 3581096
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
[TBL] [Abstract][Full Text] [Related]
4. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Ninomiya K; Sekido S; Araki T
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
Rose WC; Trader MW; Dykes DJ; Laster WR; Schabel FM
Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
[TBL] [Abstract][Full Text] [Related]
6. An improved method for analyzing survival data from combination chemotherapy experiments.
Carter WH; Stablein DM; Wampler GL
Cancer Res; 1979 Sep; 39(9):3446-53. PubMed ID: 476674
[TBL] [Abstract][Full Text] [Related]
7. Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
Holm B; Sehested M; Jensen PB
Clin Cancer Res; 1998 Jun; 4(6):1367-73. PubMed ID: 9626452
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic effect of orally administered 1-alkyl carbamoyl derivatives of 5-fluorouracil on sc implanted Lewis lung carcinoma and B16 melanoma.
Iigo M; Hoshi A; Nakamura A; Kuretani K
Cancer Treat Rep; 1979; 63(11-12):1895-9. PubMed ID: 118802
[TBL] [Abstract][Full Text] [Related]
9. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
10. [Experimental studies on antitumor effects of lysozyme].
Fukawa K; Nishimura N; Irino O; Nakazato K; Taguchi A; Nitta K
Gan To Kagaku Ryoho; 1982 May; 9(5):915-23. PubMed ID: 7184434
[TBL] [Abstract][Full Text] [Related]
11. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
Hill HZ; Hill GJ
Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
[TBL] [Abstract][Full Text] [Related]
12. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy: some concepts and results.
Skipper HE
Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
[No Abstract] [Full Text] [Related]
14. [Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
Gary-Bobo J
J Radiol Electrol Med Nucl; 1971 Dec; 52(12):858-62. PubMed ID: 4113798
[No Abstract] [Full Text] [Related]
15. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
Kline I
Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
[No Abstract] [Full Text] [Related]
16. Antitumor activity of calcium in combination with antitumor agents against Lewis lung carcinoma.
Nakano K; Fujimoto S; Tokita H
In Vivo; 1989; 3(3):147-9. PubMed ID: 2519848
[TBL] [Abstract][Full Text] [Related]
17. Modern problems of clinical chemotherapy of malignant tumours.
Perevodchikova NI; Bychkov MB
Arch Geschwulstforsch; 1980; 50(7):657-63. PubMed ID: 6263209
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
[TBL] [Abstract][Full Text] [Related]
19. [Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
Horton J; Olson K
Poumon Coeur; 1968; 24(1):59-62. PubMed ID: 4968016
[No Abstract] [Full Text] [Related]
20. Therapeutic activity of ICRF-159 combined with surgery: effects of postsurgical treatment with cyclophosphamide in mice bearing Lewis lung carcinoma lines.
Sava G; Zorzet S; Perissin L
Anticancer Res; 1985; 5(5):511-5. PubMed ID: 4062252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
